Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry.

Autor: Farisogullari B; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Türkiye., Lawson-Tovey S; Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, UK.; National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Hyrich KL; National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.; Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Gossec L; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris France; Pitié-Salpêtrière hospital, AP-HP, Rheumatology Department, Paris, France., Carmona L; Instituto de Salud Musculoesquelética, Madrid, Spain., Strangfeld A; German Rheumatism Research Center (DRFZ Berlin), Epidemiology Unit, and Charité University Medicine, Berlin, Germany., Mateus EF; Portuguese League Against Rheumatic Diseases (LPCDR), Lisbon, Portugal.; European Alliance of Associations for Rheumatology (EULAR) Standing Committee of People with Arthritis/Rheumatism in Europe (PARE), Kilchberg, Switzerland., Schäfer M; German Rheumatism Research Center (DRFZ Berlin), Epidemiology Unit, and Charité University Medicine, Berlin, Germany., Rodrigues A; Reuma.pt, Sociedade Portuguesa de Reumatologia, Lisbon, Portugal.; EpiDoC unit, CEDOC, Nova Medical School, Lisbon, Portugal.; Rheumatology Unit, Hospital dos Lusíadas, Lisbon, Portugal., Hachulla E; Service de Médecine Interne et Immunologie Clinique, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000, Lille, France., Gomez-Puerta JA; Rheumatology Department, Hospital Clinic, Barcelona, Spain.; University of Barcelona, Barcelona, Spain., Mosca M; University of Pisa and Azienda Ospedaliero Universitaria Pisana, Pisa, Italy., Durez P; Cliniques Universitaires Saint-Luc - Université catholique de Louvain (UCLouvain) - Institut de Recherche Expérimentale et Clinique (IREC), Rheumatology, Brussels, Belgium., Trefond L; Université Clermont Auvergne, CHU Clermont-Ferrand, Service de Médecine Interne, Centre de Référence pour les Maladies auto immunes et auto inflammatoires Systémiques Rares d'Auvergne, Hôpital Gabriel Montpied, Inserm U1071, INRA USC2018, M2iSH, 63000, Clermont-Ferrand, France., Goulenok T; Service de Médecine Interne, Hôpital Bichat-Claude Bernard, Assistance Publique Hôpitaux de Paris, Université de Paris, Paris, France., Cornalba M; University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy.; Dipartimento di Reumatologia e Scienze Mediche, ASST Gaetano Pini - CTO, Clinical and Pediatric Rheumatology Unit, Milan, Italy., Stenova E; 1st Department of Internal Medicine, Faculty of Medicine, University Hospital, Comenius University, Mickiewiczova 13, 82101 Bratislava, Slovakia., Bulina I; Pauls Stradins Clinical University Hospital, Riga, Latvia; Riga Stradins University, Riga, Latvia, University of Latvia, Riga, Latvia., Strakova E; Department of Internal Medicine, Faculty Hospital Prešov, Prešov, Slovakia., Zepa J; Pauls Stradins Clinical University Hospital, Riga, Latvia; Riga Stradins University, Riga, Latvia., Roux N; Service de Rhumatologie, Hôpital Robert Schuman, Metz, France., Brocq O; Rheumatology Department, Princess Grace Hospital, Monaco., Veillard E; Cabinet de Rhumatologie des 'Marines de Chasles', Saint Malo, France., Raffeiner B; Department of Rheumatology, Central Hospital of Bolzano, Bolzano, Italy., Burmester GR; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Mariette X; Department of Rheumatology, Université Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, INSERM UMR1184, Le Kremlin Bicêtre, France., Machado PM; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK p.machado@ucl.ac.uk.; Centre for Rheumatology, UCL Division of Medicine, University College London, London, UK.; National Institute for Health Research University College London Hospitals Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.; Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Oct 21; Vol. 83 (11), pp. 1584-1595. Date of Electronic Publication: 2024 Oct 21.

Comparison of Gout Flares With the Initiation of Treat-to-Target Allopurinol and Febuxostat: A Post-Hoc Analysis of a Randomized Multicenter Trial.

Autor: Barry A; Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska., Helget LN; Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska., Androsenko M; VA Boston Cooperative Studies Program Coordinating Center, Boston, Massachusetts., Wu H; VA Boston Cooperative Studies Program Coordinating Center, Boston, Massachusetts, and Babson College, Wellesley, Massachusetts., Kramer B; Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska., Newcomb JA; Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska., Brophy MT; VA Boston Cooperative Studies Program Coordinating Center and VA Boston Health Care System, Boston University, Boston, Massachusetts., Davis-Karim A; VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, New, Mexico., England BR; Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska., Ferguson R; VA Boston Cooperative Studies Program Coordinating Center and Boston University School of Medicine, Boston, Massachusetts., Pillinger MH; VA New York Harbor Health Care System and New York University Grossman School of Medicine, New York, New York., Neogi T; Boston University School of Medicine, Boston, Massachusetts., Palevsky PM; VA Pittsburgh Health Care System and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Merriman TR; University of Alabama at Birmingham., O'Dell JR; Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska., Mikuls TR; Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska.

Publikováno v: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2024 Oct; Vol. 76 (10), pp. 1552-1559. Date of Electronic Publication: 2024 Jul 15.

Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study.

Autor: Steelandt A; Rheumatology Department, University Hospital of Reims, 45 Rue Cognacq-Jay, Reims, 51100, France., Hittinger A; Rheumatology Department, University Hospital of Reims, 45 Rue Cognacq-Jay, Reims, 51100, France. ahittinger-roux@chu-reims.fr., Kanagaratnam L; Methodological Support Unit, Research and Public Health Department, University Hospital of Reims, Reims, France., Kazes I; Nephrology Department, University Hospital of Reims, Reims, France., Clavel P; Local Association for Home Dialysis Promotion (ARPDD), Hemodialysis Unit, Reims, France., Bolko L; Rheumatology Department, University Hospital of Reims, 45 Rue Cognacq-Jay, Reims, 51100, France., Rieu P; Nephrology Department, University Hospital of Reims, Reims, France., Salmon JH; Rheumatology Department, University Hospital of Reims, 45 Rue Cognacq-Jay, Reims, 51100, France.

Publikováno v: BMC nephrology [BMC Nephrol] 2024 Aug 20; Vol. 25 (1), pp. 266. Date of Electronic Publication: 2024 Aug 20.

Implementing treat-to-target urate-lowering therapy during hospitalizations for gout flares.

Autor: Russell MD; Centre for Rheumatic Diseases, King's College London, London, UK., Ameyaw-Kyeremeh L; Department of Rheumatology, King's College Hospital NHS Foundation Trust, London, UK., Dell'Accio F; Centre for Rheumatic Diseases, King's College London, London, UK., Lapham H; Department of Rheumatology, King's College Hospital NHS Foundation Trust, London, UK., Head N; Department of Rheumatology, King's College Hospital NHS Foundation Trust, London, UK., Stovin C; Department of Rheumatology, King's College Hospital NHS Foundation Trust, London, UK., Patel V; Department of Rheumatology, King's College Hospital NHS Foundation Trust, London, UK., Clarke BD; Department of Rheumatology, King's College Hospital NHS Foundation Trust, London, UK., Nagra D; Centre for Rheumatic Diseases, King's College London, London, UK., Alveyn E; Centre for Rheumatic Diseases, King's College London, London, UK., Adas MA; Centre for Rheumatic Diseases, King's College London, London, UK., Bechman K; Centre for Rheumatic Diseases, King's College London, London, UK., de la Puente MA; Department of Psychology, Health Psychology Section, Institute of Psychiatry, Psychology, & Neuroscience, King's College London, London, UK., Ellis B; Department of Rheumatology, Imperial College Healthcare NHS Foundation Trust, London, UK., Byrne C; Pharmacy Department, King's College Hospital NHS Foundation Trust, London, UK., Patel R; Pharmacy Department, King's College Hospital NHS Foundation Trust, London, UK., Rutherford AI; Department of Rheumatology, King's College Hospital NHS Foundation Trust, London, UK., Cantle F; Department of Emergency Medicine, King's College Hospital NHS Foundation Trust, London, UK., Norton S; Centre for Rheumatic Diseases, King's College London, London, UK., Roddy E; School of Medicine, Keele University, Keele, UK., Hudson J; Department of Psychology, Health Psychology Section, Institute of Psychiatry, Psychology, & Neuroscience, King's College London, London, UK., Cope AP; Centre for Rheumatic Diseases, King's College London, London, UK., Galloway JB; Centre for Rheumatic Diseases, King's College London, London, UK.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Aug 01; Vol. 63 (8), pp. 2222-2229.

Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study.

Autor: Katsumata Y; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan katsumata@twmu.ac.jp., Inoue E; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.; Showa University Research Administration Center, Showa University, Tokyo, Japan., Harigai M; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan., Cho J; National University Hospital of Singapore, Singapore., Louthrenoo W; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Hoi A; School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia., Golder V; School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia., Lau CS; The University of Hong Kong, Hong Kong, Hong Kong., Lateef A; National University Health System, Singapore., Chen YH; Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan., Luo SF; Division of Rheumatology, Allergy, and Immunology, Chang Gung Memorial Hospital, Kuei Shan, Taiwan., Wu YJ; Department of Medicine, Division of Allergy, Immunology and Rheumatology, Chang Gung University College of Medicine, Tao-Yuan, Taiwan., Hamijoyo L; Rheumatology Division, Internal Medicine, Padjadjaran University, Bandung, Indonesia., Li Z; People's Hospital Peking University Health Sciences Centre, Beijing, China., Sockalingam S; Faculty of Medicine, University of Malaya, Kuala Lumpur, Wilayah Persekutuan, Malaysia., Navarra S; University of Santo Tomas Hospital, Manila, The Philippines., Zamora L; Faculty of Medicine and Surgery, University of Santo Tomas, Manila, The Philippines., Hao Y; University of Melbourne at St Vincent's Hospital, Fitzroy, Victoria, Australia., Zhang Z; Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China., Chan M; Tan Tock Seng Hospital, Singapore., Oon S; Department of Medicine, The University of Melbourne at St Vincent's Hospital, Fitzroy, Victoria, Australia., Ng K; Waitemata District Health Board, Auckland, New Zealand., Kikuchi J; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan., Takeuchi T; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.; Saitama Medical University, Saitama, Japan., Goldblatt F; Repatriation General Hospital, Daw Park, South Australia, Australia., O'Neill S; University of New South Wales, Sydney, New South Wales, Australia.; Ingham Institute of Applied Medical Research, Liverpool, New South Wales, Australia., Tugnet N; Auckland District Health Board, Auckland, New Zealand., Law AHN; Rheumatology and Immunology, Singapore General Hospital, Singapore., Bae SC; Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea (the Republic of).; Hanyang University Institute for Rheumatology Research, Seoul, Korea (the Republic of).; Hanyang Institute of Bioscience and Biotechnology, Seoul, Korea (the Republic of)., Tanaka Y; First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Ohkubo N; First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Kumar S; Middlemore Hospital, Auckland, New Zealand., Kandane-Rathnayake R; School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia., Nikpour M; Department of Medicine, University of Melbourne, Fitzroy, Victoria, Australia.; The University of Sydney School of Public Health, Sydney, New South Wales, Australia., Morand EF; School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Jul 15; Vol. 83 (8), pp. 998-1005. Date of Electronic Publication: 2024 Jul 15.